• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Several Lots of Human Growth Hormone Have Been Recalled

News
Article

An FDA inspection of compound pharmacy Innoveix Pharmaceuticals indicated these lots may not be sterile.

Innoveix Pharmaceuticals, a compounding pharmacy in Addison, Tex., is voluntarily recalling several lots of compounded drug products. The products are being recalled due to a lack of assurance of sterility. The issues where discovered during a routine inspection by the FDA.

The affected products are injectable sermorelin/ipamorelin 3mg and injectable AOD-9604 3mg. Sermorelin and ipamorelin are human growth hormone secretagogues (GHSs), which are compounds that increase growth hormone release. AOD is a synthetic peptide thought to have potential for weight loss.

To date, Innoveix Pharmaceuticals has not received any reports of adverse events related to this recall.

Sermorelin / Ipamorelin 3mg

  • Lot# SIP210; Exp: 12/15/2021
  • Lot# SIP215; Exp: 01/14/2022
  • Lot# SIP220; Exp: 01/23/2022

AOD-9604 3mg

  • Lot# AOD205; Exp: 11/09/2021
  • Lot# AOD210; Exp: 11/18/2021
  • Lot# AOD 215; Exp: 12/15/2021
  • Lot# AOD202; Exp: 11/09/2021
Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.